WO2024050521A2 - Dispositif de lunettes photothérapeutiques et kit associé - Google Patents

Dispositif de lunettes photothérapeutiques et kit associé Download PDF

Info

Publication number
WO2024050521A2
WO2024050521A2 PCT/US2023/073327 US2023073327W WO2024050521A2 WO 2024050521 A2 WO2024050521 A2 WO 2024050521A2 US 2023073327 W US2023073327 W US 2023073327W WO 2024050521 A2 WO2024050521 A2 WO 2024050521A2
Authority
WO
WIPO (PCT)
Prior art keywords
lens
phototherapeutic
wavelength range
light
eyewear device
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2023/073327
Other languages
English (en)
Other versions
WO2024050521A3 (fr
Inventor
Todd Bracher
Fredric Maxik
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Todd Bracher Studio LLC
Original Assignee
Todd Bracher Studio LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Todd Bracher Studio LLC filed Critical Todd Bracher Studio LLC
Publication of WO2024050521A2 publication Critical patent/WO2024050521A2/fr
Publication of WO2024050521A3 publication Critical patent/WO2024050521A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C11/00—Non-optical adjuncts; Attachment thereof
    • G02C11/04—Illuminating means
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/10—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses
    • G02C7/104—Filters, e.g. for facilitating adaptation of the eyes to the dark; Sunglasses having spectral characteristics for purposes other than sun-protection
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C9/00—Attaching auxiliary optical parts
    • G02C9/04—Attaching auxiliary optical parts by fitting over or clamping on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0635—Radiation therapy using light characterised by the body area to be irradiated
    • A61N2005/0643—Applicators, probes irradiating specific body areas in close proximity
    • A61N2005/0645—Applicators worn by the patient
    • A61N2005/0647—Applicators worn by the patient the applicator adapted to be worn on the head
    • A61N2005/0648—Applicators worn by the patient the applicator adapted to be worn on the head the light being directed to the eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/065—Light sources therefor
    • A61N2005/0657—Natural light sources, e.g. captured sunlight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N2005/0664—Details
    • A61N2005/0667—Filters
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C2200/00—Generic mechanical aspects applicable to one or more of the groups G02C1/00 - G02C5/00 and G02C9/00 - G02C13/00 and their subgroups
    • G02C2200/02—Magnetic means

Definitions

  • the present invention relates to a phototherapeutic eyewear device and a kit for the same.
  • a phototherapeutic eyewear device comprising a frame structure comprising one or more lens attachment sections and one or more lens apparatuses, each lens apparatus comprising an attachment section configured to removably attach the lens apparatus to the one or more lens attachment sections and a lens member comprising a first transparent member and an optical modification member configured to modify the intensity of light within a first wavelength range to facilitate a phototherapeutic effect in the wearer of the phototherapeutic eyewear device.
  • the optical modification member may be one of a film adhered to the first transparent member, a material sprayed onto the first transparent member, or may be integrally formed with the first transparent member.
  • the optical modification member may be configured to decrease the intensity of light within the first wavelength range.
  • the first wavelength range may be a range from 400 nm to 510 nm.
  • the first wavelength range may be a range from 450 nm to 470 nm.
  • the optical modification member may be further configured to increase the intensity of light within a second wavelength range.
  • the optical modification member may comprise one of a fluorescent material, a phosphorescent material, and a quantum dot material.
  • the second wavelength range may be a range from one of 625 nm to 740 nm, 605 nm to 660 nm, and 800 to 810 nm.
  • each lens apparatus further may comprise a second transparent member and the optical modification member may be positioned between the first transparent member and the second transparent member.
  • the phototherapeutic eyewear device may further comprise a light emitting apparatus configured to emit light in the direction of the lens member and be observable by a wearer of the phototherapeutic eyewear device within a second wavelength range.
  • the second wavelength range may be a range from one of 625 nm to 740 nm, 605 nm to 660 nm, and 800 to 810 nm.
  • the lens attachment section may comprise a magnetic material and the attachment section may be configured to magnetically attach to the lens attachment section.
  • kits comprising a frame structure comprising one or more lens attachment sections and first and second sets of lens apparatuses, each lens apparatus comprising an attachment section configured to removably attach the lens apparatus to the one or more lens attachment sections and a lens member comprising a first transparent member and an optical modification member configured to modify the intensity of light within a wavelength range to facilitate a phototherapeutic effect in the wearer of the phototherapeutic eyewear device;
  • the optical modification member of the first set of lens apparatuses may be configured to modify light within a first wavelength range
  • the optical modification member of the second set of lens apparatuses may be configured to modify light within a second wavelength range.
  • the optical modification member of the first set of lens apparatuses may be configured to reduce the intensity light within the first wavelength range from 400 nm to 510 nm and the optical modification member of the second set of lens apparatuses may be configured to increase the intensity light within the second wavelength range from 800 to 810 nm.
  • the optical modification member of the first set of lens apparatuses may be configured to reduce the intensity light within the first wavelength range from 450 nm to 470 nm and increase the intensity of light within a third wavelength range from 605 nm to 660 nm and the optical modification member of the second set of lens apparatuses may be configured to decrease the intensity light within the second wavelength range from 450 nm to 470 nm and increase the intensity of light within a fourth wavelength range from 800 nm to 810 nm.
  • the first set of lens apparatuses comprise light emitting apparatus configured to emit light in the direction of the lens member and be observable by a wearer of the phototherapeutic eyewear device within a third wavelength range from 605 nm to 660 nm.
  • the second set of lens apparatuses comprise light emitting apparatus configured to emit light in the direction of the lens member and be observable by a wearer of the phototherapeutic eyewear device within a third wavelength range from 800 nm to 810 nm.
  • FIG. 1 is a perspective view of a phototherapeutic eyewear device according to an embodiment of the invention.
  • FIG. 2 is a perspective view of a lens of the phototherapeutic eyewear device of FIG. 1.
  • FIG. 3 is a side sectional view of a lens apparatus according to an embodiment of the invention.
  • FIG. 4 is a side sectional view of a lens apparatus according to an embodiment of the invention.
  • FIG. 5 is a perspective view of the lens of FIG. 2 with a portion thereof removed.
  • FIG. 6 is a perspective view of the phototherapeutic eyewear device of FIG. 1 with the lens apparatuses detached from a frame structure thereof.
  • FIG. 7 is a perspective view of a phototherapeutic eyewear device kit according to an embodiment of the invention.
  • FIGS. 1 , 2, 5, and 6 An embodiment of the invention, as shown and described by the various figures and accompanying text, provides a phototherapeutic eyewear device.
  • a phototherapeutic eyewear device 100 As shown in FIGS. 1 , 2, 5, and 6, a phototherapeutic eyewear device 100 according to an embodiment of the invention is presented.
  • the phototherapeutic eyewear device 100 may comprise a frame structure 110 and one or more phototherapeutic lens apparatuses 120.
  • the phototherapeutic lens apparatuses 120 may be fixedly attached to the frame structure 110 by any means or method as is known in the art, including, but not limited to, interference fits between the phototherapeutic lens apparatuses 120 and a portion of the frame structure 110, the phototherapeutic lens apparatuses 120 comprising a depression within which an extruding ridge and/or a thread member of a portion of the frame structure 110 may be positioned, the use of adhesives and/or glues, the use of fasteners, and the like.
  • the phototherapeutic lens apparatuses 120 may be removably attached to the frame structure 110 by any means or method as is known in the art, including the above methods (in some embodiments excluding glues and adhesives) wherein the attachment is detachable, magnetic attachment, and the like. Such removable attachment will be discussed in greater detail below.
  • the phototherapeutic lens apparatuses 120 may be configured to alter the spectral power distribution SPD of light incident thereupon and observed by a wearer of the phototherapeutic eyewear device 100. Such alteration may result in an SPD intended to one of induce a biological response and avoid an induced biological response in the wearer of the phototherapeutic eyewear device 100.
  • a phototherapeutic lens apparatus 120 may comprise a lens member 122.
  • the lens member 122 may be at least partially transparent to light within the visible spectrum (electromagnetic radiation (EMR) having a wavelength within a range from 380 nanometers (nm) to 750 nm).
  • EMR electromagnetic radiation
  • the lens member 122 may be at least partially transparent to light within a near infrared spectrum (EMR having a wavelength from 750 nm to 1 .4 micrometers) and/or within a range of ultraviolet light (for example, EMR having a wavelength within a range from 315 nm to 400 nm).
  • the lens member 122 may be configured, by active or passive means, method, or structure, to increase or decrease the light emitted form the lens member 122 in the direction of the wearer within one or more wavelength ranges to accomplish the aforementioned biological responses.
  • the phototherapeutic lens apparatus 120 may comprise one or more structures operable to accomplish modification of the SPD of environmental light propagating therethrough.
  • the phototherapeutic lens apparatus 120 may comprise a transparent member 123 and an optical modification member 124.
  • the optical modification member 124 may be fixedly attached to the transparent member
  • the optical modification member 124 may be a film configured to adhere to the transparent member
  • the optical modification member 124 may be in the form of a material that is sprayed onto the transparent member 123. These embodiments are exemplary only, and any means or method of affixing the optical modification member
  • the optical modification member 124 and the transparent member may be integrally formed and/or formed as a single structure, with an optically effective material either forming or being contained within the transparent member 123.
  • the optical modification member 124 may be configured to at least one of increase and decrease the intensity of light within a target wavelength range. Where the optical modification member 124 is configured to decrease the intensity of light within the target wavelength range, it may be configured as a filter configured to absorb at least a portion of light within the target wavelength range, in some embodiments absorbing all light within the target wavelength range. In some embodiments, the optical modification member 124 may be configured to decrease the intensity of light within a first target wavelength range and increase the intensity of light within a second target wavelength range. In such embodiments, the optical modification member 124 may be configured to absorb some or all light within the first target wavelength range and emit light within the second target wavelength range.
  • the optical modification member 124 may comprise a material operable to absorb light within a first wavelength range and emit light within a second wavelength range as is known in the art, including, but not limited to, fluorescent material, phosphorescent material, quantum dots, and any other photoluminescent materials as are known in the art.
  • the ranges selected for the first and second target wavelength ranges may determine the biological affect that is enhanced or inhibited by the phototherapeutic lens apparatus 120.
  • the phototherapeutic lens apparatus 120 may be configured to inhibit the progression of myopia.
  • the phototherapeutic lens apparatus 120 may be configured to generally reduce or inhibit the irradiation of the eyes of the wearer with blue light, for example, light within a wavelength range from 400 nm to 510 nm, in further embodiments within a wavelength range from 420 nm to 490 nm, in further embodiments within a wavelength range from 430 nm to 480 nm, in further embodiments within a wavelength range from 450 nm to 470.
  • the first wavelength range may comprise EMR having a peak wavelength centered within a range from 450 to 470 nm and a half-bandwidth within a range from 5 nm to 10 nm.
  • the phototherapeutic lens apparatus 120 may be configured to increase the intensity of light within the second wavelength range, the second wavelength range being different from the first wavelength range.
  • the second wavelength range may correspond to light within one or both of a red portion of the visible spectrum and the infrared spectrum, including within a range from 625 nm to 740 nm, within a range from 635 nm to 730 nm, within a range from 605 nm to 660 nm, and light having a peak intensity at a wavelength within a range from 605 nm to 660 nm and having a half-bandwidth within a range from 5 nm to 10 nm.
  • the first transparent member 123 may be formed of any material used in the art for eyeglass lenses, including, but not limited to, polycarbonate, plastics, Trivex®, glass, and the like.
  • FIG. 4 An alternate embodiment is shown in FIG. 4, where the lens member 122 may comprise first and second transparent members 123, 125 and an optical modification member 124 positioned therebetween. Such an embodiment may reduce the chance of damage to the optical modification member 124.
  • optical modification member 124 is presented, it is contemplated and included within the scope of the invention that any number of optical modification members may be comprised by the lens member 122. Such embodiments may have multiple target wavelength ranges as discussed above.
  • the phototherapeutic lens apparatus 120 may further comprise a light emitting apparatus 126.
  • the light emitting apparatus 126 may be operable to emit light within a wavelength range as described above, where an increase in the intensity of light within the wavelength range is desired.
  • the light emitting apparatus 126 may be configured to emit light in the direction of the lens member 122 such that light emitted thereby is observed by the wearer.
  • the light emitting apparatus 126 may comprise light-emitting devices configured to emit light within a target wavelength range. Such devices may include, but are not limited to, semiconductor devices, such as light-emitting diodes (LEDs), including organic LEDs, phosphorescent LEDs, and the like.
  • LEDs light-emitting diodes
  • a further embodiment of the invention may be directed to treating cataracts.
  • one or both of the optical modification member 124 and the light emitting apparatus 126 may emit light within a wavelength range from 800 nm to 810 nm, and/or emit light having a peak intensity at 805 nm with a 5-10 nm half-bandwidth.
  • the phototherapeutic lens apparatus 120 may further comprise an attachment section 127.
  • the attachment section 127 may be configured to removably attach the phototherapeutic lens apparatus 120 to the frame structure 110 by any means or method as is known in the art.
  • at least a portion of the attachment section 127 may be magnetic and figured to magnetically attract a portion of the frame structure 110. The magnetic attraction there between may removably attach the phototherapeutic lens apparatus 120 to the frame structure 110.
  • the attachment section 127 may be configured to be positioned at least partially within a structure of the frame structure 110 and form an interference fit therebetween.
  • a user may have multiple discrete phototherapeutic lens apparatus 120, each phototherapeutic lens apparatus 120 being configured to have a different biological effect, and accordingly being configured to have light emitted from the phototherapeutic lens apparatus 122 having different SPDs.
  • Such removability and interchangeability may enable a user to tailor the phototherapeutic eyewear device 100 according to their immediate needs.
  • attachment sections 127 of the lens apparatuses 120 may be configured to attach to corresponding lens attachment sections 112 of the frame structure 110.
  • the lens attachment sections 112 may generally conform to the shape of the lens apparatuses 120; in the present embodiment, they are circular.
  • the frame structure 110 may further comprise a bridge 113 between the lens attachment sections 112, end pieces 114 extending from the lens attachment sections 112, temples 115 that may be rotatably attached at one end thereof to the end sections 114, and temple tips 116 at an opposite end of the temples 115.
  • the lens attachment sections 112 may form the rims of the phototherapeutic eyewear device 100.
  • the lens attachment section 112 may perform attachment functionality, while the remainder serves an ornamental purpose and/or provides support for the lens apparatus 120 but does not facilitate attachment.
  • the lens attachment section 112 may comprise a magnetic material operable to interact with the magnetic field generated by the attachment section 127 to removably attach the lens apparatus 120.
  • the lens apparatuses 120 may be removably attached to the frame structure 110 by positioning them adjacent to the lens attachment sections 112, such that the above magnetic attraction is accomplished.
  • the lens apparatuses 120 may be positioned within an aperture 117 formed by the lens attachment sections 112 and form an interference fit, thereby removably attaching the lens apparatuses 120.
  • the frame structure 110 may comprise one or more corrective lenses (not shown).
  • the corrective lenses may be any corrective lens as is known in the art and configured to address eye disorders, such as, but not limited to, myopia, hyperopia, and astigmatism, by modalities other than the phototherapy performed by the lens apparatuses 120.
  • the corrective lenses may refract the light passing therethrough to address such eye disorders.
  • the SPD of light passing therethrough may not be affected.
  • the corrective lenses may be positioned within the aperture 117 at a location comparatively proximal to the eye of the wearer, and the lens apparatuses 120 may be positioned at a location comparatively distal to the eye of the wearer relative to the corrective lenses. Accordingly, the light emitted from the lens apparatuses 120 may maintain the same SPD as it passes through the corrective lenses.
  • At least one of the frame structures 110 and the lens apparatus 120 may comprise a battery (not shown).
  • the battery may provide electrical power for the operation of the light-emitting apparatus 126.
  • the removable attachment of the lens apparatuses 120 to the frame structure 110 may simultaneously establish an electrical connection between the battery and the light-emitting apparatus 126.
  • Such connection may be accomplished by at least one of causing the physical engagement between electrical pads comprised by the lens apparatus 120 and the frame structure 110 or placing an inductive charging system, the transmission portion comprised by the frame structure 110 and the receiving portion comprised by the lens apparatus 120, in sufficiently close proximity to allow for the wireless transfer of power.
  • the kit 700 may comprise a container 702 having positioned there within a frame structure 704 substantially as described above, a first set of lens apparatuses 706 configured to accomplish a first spectral power distribution to cause a first biological effect, and a second set of lens apparatuses 708 configured to accomplish a second spectral power distribution to cause a second biological effect.
  • the first and second SPDs may be different, and the first and second biological effects may also be different.

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Pathology (AREA)
  • Eyeglasses (AREA)

Abstract

L'invention concerne un dispositif de lunettes photothérapeutique (100) comprenant une structure de monture (110) comprenant une ou plusieurs sections de fixation de lentille (112) et un ou plusieurs appareils de lentille (120), chaque appareil de lentille (120) comprenant une section de fixation (127) configurée pour fixer de manière amovible l'appareil de lentille (120) à la ou aux sections de fixation de lentille (112) et un élément de lentille (122) comprenant un premier élément transparent (123) et un élément de modification optique (124) configuré pour modifier l'intensité de la lumière dans une première plage de longueurs d'onde pour faciliter un effet photothérapeutique dans le porteur du dispositif de lunettes photothérapeutiques.
PCT/US2023/073327 2022-09-02 2023-09-01 Dispositif de lunettes photothérapeutiques et kit associé Ceased WO2024050521A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202263374389P 2022-09-02 2022-09-02
US63/374,389 2022-09-02

Publications (2)

Publication Number Publication Date
WO2024050521A2 true WO2024050521A2 (fr) 2024-03-07
WO2024050521A3 WO2024050521A3 (fr) 2024-05-02

Family

ID=90098827

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2023/073327 Ceased WO2024050521A2 (fr) 2022-09-02 2023-09-01 Dispositif de lunettes photothérapeutiques et kit associé

Country Status (1)

Country Link
WO (1) WO2024050521A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4537895A1 (fr) * 2023-10-12 2025-04-16 Essilor International Ensemble ophtalmique pour le contrôle de la progression de la myopie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7984989B2 (en) * 2008-02-07 2011-07-26 Gruber Jake A Retinal melatonin suppressor comprising a filter layer
US9726910B2 (en) * 2013-07-12 2017-08-08 Photoprotective Technologies Incorporated Phototherapeutic near IR fluorescent light filters
CN109477990A (zh) * 2016-04-13 2019-03-15 埃弗里克斯股份有限公司 带有干涉滤光器的眼镜制品
WO2021262452A1 (fr) * 2020-06-23 2021-12-30 Lumitex, Inc. Dispositif de photothérapie et de photobiomodulation

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4537895A1 (fr) * 2023-10-12 2025-04-16 Essilor International Ensemble ophtalmique pour le contrôle de la progression de la myopie
WO2025078650A1 (fr) * 2023-10-12 2025-04-17 Essilor International Ensemble ophtalmique pour le contrôle de la progression de la myopie

Also Published As

Publication number Publication date
WO2024050521A3 (fr) 2024-05-02

Similar Documents

Publication Publication Date Title
US10315043B2 (en) Method and device for monitoring and treatment of seasonal affective disorder
US11650434B2 (en) Optical systems, spectacle lens and eyewear including the same
US12226647B2 (en) Method and apparatus for treating refractive error of the eye
KR20210032529A (ko) 근시 진행을 감소시키기 위한 전자 콘택트 렌즈의 광학 설계
JP3243788U (ja) 抗周辺部遠視性デフォーカス用シート及び眼鏡
RU2012148122A (ru) Контактные линзы с антибликовым эффектом в условиях искусственного освещения
US9044567B2 (en) Phototherapy method and device
US20220283450A1 (en) Ophthalmic set for myopia progression control
CN105759333A (zh) 眼科防困镜片、器件、及方法
WO2024050521A2 (fr) Dispositif de lunettes photothérapeutiques et kit associé
US12337191B2 (en) Color balanced sunglass lens for ocular photo-bio-stimulation
US20230120782A1 (en) Phototherapy and photobiomodulation device
US11460721B2 (en) Illuminated eyewear device
US20160026005A1 (en) Eyewear and lenses therefor
US20020044254A1 (en) Tinted contact lens and method for treatment of migraine headaches
US20070025118A1 (en) Method and apparatus for reducing visual aberrations
US20230273461A1 (en) Augmenting pre-existing eyeglasses with electronic capabilities to treat one or more ocular conditions
Good Light and eye damage
WO2020070243A1 (fr) Dispositif de photothérapie
US12551718B2 (en) Electromagnetic and photobiomodulation devices for treating eye disorders and methods of using the same
US10620451B1 (en) Eyeglasses with removable lens
US20220413320A1 (en) Activity specific contact lenses
US20250281770A1 (en) Color Balanced Sunglass Lens for Ocular Photo-Bio-Stimulation
US12616849B2 (en) Sunglass lens and sunglass optics for ocular photo-bio-stimulation
US20250332440A1 (en) Method for Slowing or Stopping Myopia Progression

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23861605

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 23861605

Country of ref document: EP

Kind code of ref document: A2